0% found this document useful (0 votes)
40 views37 pages

Delirium

The document discusses delirium, including its DSM-5 criteria, signs and symptoms, risk factors, and pathophysiology. It aims to help medical professionals recognize delirium by listing its prevalence in different patient populations, common causes, and consequences like increased mortality. The temporal course, cognitive and perceptual symptoms are outlined. Differential diagnosis from dementia and depression is also reviewed.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
40 views37 pages

Delirium

The document discusses delirium, including its DSM-5 criteria, signs and symptoms, risk factors, and pathophysiology. It aims to help medical professionals recognize delirium by listing its prevalence in different patient populations, common causes, and consequences like increased mortality. The temporal course, cognitive and perceptual symptoms are outlined. Differential diagnosis from dementia and depression is also reviewed.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 37

Delirium (When things really do go bump in the night!

)
Dr sadia yasir

ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY


Psychiatrists Providing Collaborative Care Bridging Physical and Mental Health
Objectives

 List DSM-5 criteria for delirium


 Identify signs and symptoms of delirium
 Identify risk factors for delirium
 Recognize common precipitating causes of delirium
 Describe differences between delirium and other similar disorders
 Describe the assessment and treatment for patients with delirium

Academy of Consultation-Liaison Psychiatry 2


Sequence of presentation

 DSM-5 Criteria
 Synonyms and terminology
 Prevalence
 Recognition
 Risk Factors
 Clinical features
 Pathophysiology
 A CASE PRESENTATION
 Etiology
 Assessment
 Treatment
 Prevention

Academy of Consultation-Liaison Psychiatry 3


DSM 5 Criteria - Delirium
• Disturbance in attention and awareness
• Develops over short period; fluctuates
• Additional disturbance in cognition
• Not accounted for by other neurocognitive disorders
• Caused by a general medical condition
• Can be multiple etiologies

American Psychiatric Association: Diagnostic and Statistical


Manual of Mental Disorders, 5th Edition. Arlington, VA,
Academy of Consultation-Liaison Psychiatry
American Psychiatric Association, 2013. 4
DSM 5 Criteria
• Classification of delirium
– Delirium due to another medical condition
– Substance intoxication delirium
– Substance withdrawal delirium
– Delirium due to multiple etiologies
– Medication induced delirium

Academy of Consultation-Liaison Psychiatry 5


DSM 5 Criteria

 Further Specifiers
– Time
 Acute : Hours/Days
 Persistent: Weeks/Months
– Level of activity
 Hyperactive
 Hypoactive
 Mixed level of activity

Academy of Consultation-Liaison Psychiatry


Synonyms for Delirium

• Acute confusional state


• Encephalopathy
• Acute brain failure
• ICU psychosis
• Altered mental status
• Acute reversible psychosis
• Reversible dementia
• Acute mental status change
• Organic brain syndrome
Academy of Consultation-Liaison Psychiatry
Prevalence of Delirium
Prevalence %

Severe burn

Nursing home

Terminally ill patients

Post repair of fractured hip

Post CABG

Post op patients

AIDS

ICU elderly

Hospitalzed cancer

Hospitalized elderly

Hospitalized medically ill

ER

0 10 20 30 40 50 60 70 80 90

Academy of Consultation-Liaison Psychiatry


Recognition of Delirium

• Delirium is commonly unrecognized


– ER physicians miss 87-83% of cases (Han, Wilson & Ely, 2013)
– Hospital admission 14-24% (overall prevalence 1-2%) (Fong, Tulebaev & Inouye, 2011)
– Nurses recognize delirium more frequently than physicians, 45% v. 20%
• Delirium should always be considered when there is an acute or
subacute deterioration in behavior, cognition or function
• 30-40% of delirium cases are preventable (Hshieh, et. Al, 2015)

Academy of Consultation-Liaison Psychiatry


Consequences of Delirium

• Increased Mortality
– Almost 25% more chances of death with delirium in hospitalized patients (Curyto et. al, 2007)
– Adjusted risk of death – twice as compared to non-delirious controls (Inouye et. al, 1998)

• Increased Morbidity
– Poor functional recovery
– Possible future cognitive decline
– Increased risk of complications
– Increased nursing home placement
– Increased costs and LOS
– Depression, PTSD

Academy of Consultation-Liaison Psychiatry


Risk Factors for Delirium
(Partial List)
• Elderly
– Impaired acetylcholine neurotransmission
– Vascular changes
– Pharmacokinetic changes
• CNS disorders
– Major neurocognitive disorders represents one of the greatest risk factors
• Multiple medications (including starting more than 3-5 new meds)
• Burn patients
• Low serum albumin
• Drug and Alcohol Abuse

Academy of Consultation-Liaison Psychiatry


Clinical Features of Delirium

• Temporal course
– Abrupt or acute onset
• Within days
– Fluctuation in symptom severity
• Waxing and waning
• Worse at night
• May result in diagnostic uncertainty

Academy of Consultation-Liaison Psychiatry


Clinical Features

• Diffuse cognitive impairment


– Attentional deficits
• Reduced ability to focus, sustain or shift attention
• “Clouding of consciousness”
– Memory impairment
• Long and short term
– Disorientation
• Commonly to time and place
• Rarely to person
– Executive dysfunction

Academy of Consultation-Liaison Psychiatry


Clinical Features

• Thought disturbances
– Disorganized
• Language disturbances
– Word finding problems
– Dysgraphia
– Dysarthria
– Dysnomia
• Perceptual disturbances
– Misperceptions
– Hallucinations (Visual >> Auditory)
Academy of Consultation-Liaison Psychiatry
Clinical Features

• Psychomotor abnormalities
– Hyper, hypo or mixed
• Sleep-wake cycle disturbance
– Insomnia
– Frequent napping or drowsiness during the day
– Reversal of sleep/wake cycle
• Delusions
– Usually paranoid and not systematized
• Affective lability
• Neurologic abnormalities
Academy of Consultation-Liaison Psychiatry
Differential Diagnosis of Delirium
Delirium Dementia Depression
Onset Abrupt Slow and insidious Variable

Daily Course Fluctuating Usually stable Usually stable


Length Hours to weeks Years Variable
Consciousness Reduced Clear Clear
Alertness Increased or Usually normal Normal
decreased
Activity Increased or Variable Variable
decreased
Attention Impaired Usually normal Usually normal
Orientation Impaired Impaired Normal

16
Pathophysiology of Delirium: Acetylcholine
• Acetylcholine
– The cholinergic system is involved in:
• Attention
• Arousal
• Memory
– Decreased cholinergic activity produces deficits in:
• Information processing
• Arousal
• Attention and ability to focus
– Various metabolic insults, thiamine deficiency and anti-cholinergic medications all can produce
delirium through a decrease in cholinergic activity

Academy of Consultation-Liaison Psychiatry


Pathophysiology of Delirium: Dopamine

• Dopamine
– An excess of dopamine may be a source of the agitation, delusions and psychosis
in delirious patients
– There is an inverse relationship between dopamine and acetylcholine levels
– Dopaminergic agents may induce delirium
– Dopamine antagonists are an effective treatment for delirium

Academy of Consultation-Liaison Psychiatry


Etiology of Delirium

• Identification of underlying cause is paramount to treatment


• Common causes
– General medical conditions
– Medications
– Substance intoxication
– Substance withdrawal
– Multiple etiologies

Academy of Consultation-Liaison Psychiatry


Etiology of Delirium
• Intoxication with drugs
– Many drugs implicated, especially anticholinergic agents, NSAIDs, antiparkinsonism agents,
antimicrobials, steroids, opiates, sedative-hypnotics, and illicit drugs
• Withdrawal syndromes
– Alcohol, sedative-hypnotics, and barbiturates
• Metabolic causes
– Hepatic, renal or pulmonary insufficiency
– Endocrinopathies such as hypothyroidism, hyperthyroidism, hypopituitarism or hypoglycemia
– Disorders of fluid and electrolyte balance

Academy of Consultation-Liaison Psychiatry


Etiology of Delirium
• Infections
– Sepsis, meningitis, pneumonia, syphilis and urinary tract infection
• Head trauma
– Subdural hematoma, closed head injury/concussion
• Epilepsy
• Neoplastic disease
– CNS metastasis or limbic encephalopathy
• Vascular disorders
– Cerebrovascular (stroke)
– Cardiovascular (acute MI, ACS, Hypertensive Emergency)

Academy of Consultation-Liaison Psychiatry


Life Threatening Causes of Delirium
(Caplan and Stern, 2008)
 W: Wernicke's encephalopathy; withdrawal (alcohol or BZDs)
 H: Hypoglycemia; hypoxia; hypoperfusion of CNS; hypertensive crisis, hyper or
hypothermia
 I: Infections; intracranial processes
 M: Metabolic derangements; Meningitis/encephalitis
 P: Poisons
 S: Seizures (status epilepticus)

Academy of Consultation-Liaison Psychiatry


Assessment of Delirium

• Recognition
• Consider screening tool for ancillary staff (e.g. brief cognitive assessment)
• History
– Establish course of mental status changes
• Talk to family or caregivers
• Recent medication change(s)
• Symptoms of medical illness
• Review medical record
• Review anesthesia record if post-op
– Onset of delirium is best clue to causality

Academy of Consultation-Liaison Psychiatry


Assessment of Delirium

• Physical and neurologic examination


– Vitals and focused physical exam
• Mental status
– Observe for behavioral signs
• Cognitive tests
– Folstein Mini Mental State Exam
– Clock drawing task
– Digit span
– Months backwards

Academy of Consultation-Liaison Psychiatry


Assessment of Delirium

• Basic laboratory test • Additional tests


– Blood chemistries – ECG
– Complete blood count – EEG
– Hepatic function panel – Cardiac enzymes
– TSH – HIV
– B12 and folate – Chest X-ray
– RPR – ANA, RF, CRP
– ABG – Lumbar puncture
– Serum drug levels – Blood cultures
– Urinalysis and collection for culture – Heavy metals
– CT or MRI

Academy of Consultation-Liaison Psychiatry 25


Assessment of Delirium
• Electroencephalogram
– Helpful to confirm the diagnosis
– Usually generalized slowing
– Low voltage fast activity in alcohol or sedative-hypnotic withdrawal
– Picture: Delirium Detection Using EEG
• Structural Neuroimaging
– Focal neurologic signs
– History or concern of head trauma
– No clear cause of delirium found

Academy of Consultation-Liaison Psychiatry


Treatment of Delirium

• Two important aspects


–Identify and reverse the reason(s) for the delirium
–Managing behaviors
– Sitter
– Restraints (Not appropriate)
– Reduce psychiatric or behavioral symptoms of delirium
• Non pharmacologic treatment
• Pharmacologic treatment

Academy of Consultation-Liaison Psychiatry


Treatment of Delirium

• Non-pharmacologic Interventions
– Aims
• Cognitively non-demanding
• Limit the risk of harm to self and/or others
– Types
• Avoid interruption of sleep
• Room close to nursing station
• Sitter, feeding assistance and encouragement during meals
• Clocks and calendar and orientation board
• Adequate lighting
• Sensory aids, cleaning of ear wax

Academy of Consultation-Liaison Psychiatry


Treatment of Delirium

• Major classes of medications utilized


– Antipsychotics
• Typical
• Atypical
– Cholinesterase inhibitors
– Benzodiazepines

Academy of Consultation-Liaison Psychiatry


Predisposing Factors to Delirium (targets for prevention efforts)

 Cognitive impairment or disorientation


 Dehydration or constipation
 Hypoxia
 Immobility or limited mobility
 Infection
 Multiple medications
 Pain
 Poor nutrition
 Sensory impairment
 Sleep disturbance

Academy of Consultation-Liaison Psychiatry


Take Home Points
• Delirium is acute alteration in cognitive functioning with fluctuations in
attention span and other symptoms
• Delirium is a serious, though under-recognized condition
• Frailty increases risk of delirium
• Management involves maximization of medical condition while
minimization of polypharmacy
• Prevention, detection and education are key

Academy of Consultation-Liaison Psychiatry


REFERENCES
 Brown TM and Boyle MF: Delirium. BMJ. 325(7365):644-7, 2002.
 Brown, E. G. and V. C. Douglas (2015). "Moving Beyond Metabolic Encephalopathy: An Update on Delirium
Prevention, Workup, and Management." Semin Neurol 35(6): 646-655.
 Brickman AM, Honig LS, Scarmeas N, et al. Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to
Predict the Rate of Cognitive Decline in Alzheimer Disease. Arch Neurol. 2008;65(9):1202–1208.
doi:10.1001/archneur.65.9.1202
 Caplan JP and Stern TA: Mnemonics in a mnutshell: 32 aids to psychiatric diagnosis. Current Psychiatry 7(10):27-33,
2008.
 Christina J. Hayhurst, Pratik P. Pandharipande, Christopher G. Hughes; Intensive Care Unit Delirium: A Review of
Diagnosis, Prevention, and Treatment. Anesthesiology 2016;125(6):1229-1241. doi:
10.1097/ALN.0000000000001378.
 Curyto KJ, Johnson J, TenHave T, et al: Survival of hospitalized elderly patients with delirium: a prospective study.
Am J Geriatr Psychiatry 9:141-147, 2001.
 Delirium, NICE Clinical Guideline (July 2010). http://guidance.nice.org.uk/CG103. Reviewed 2015 without updates
added

Academy of Consultation-Liaison Psychiatry


REFERENCES

 Devlin, JW et al. “Impact of Quetiapine on resolution of individual delirium symptoms in critically ill patients with
delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study”. Critical Care; vol. 15(5):
R215; September 17, 2011.
 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association,
Washington, D.C., 2013.
 Drake, Robert E, Caton, Carol, et al. “A Prospective 2-Year Study of Emergency Department Patients with Early-
Phase Primary Psychosis or Substance-Induced Psychosis”. American Journal of Psychiatry 168:7; pp.742-748, July
2011.
 European Delirium Association, American Delirium Society (2014). The DSM-5 criteria, level of arousal and
delirium diagnosis: inclusiveness is safer. BMC medicine, 12, 141. doi:10.1186/s12916-014-0141-2
 Flaherty, J. H., et al. (2017). "Dissecting Delirium: Phenotypes, Consequences, Screening, Diagnosis, Prevention,
Treatment, and Program Implementation." Clin Geriatr Med 33(3): 393-413.
 Flurie, R. W., et al. (2015). "Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive
care unit to discharge." Am J Health Syst Pharm 72(23 Suppl 3): S133-139.

Academy of Consultation-Liaison Psychiatry 33


REFERENCES

 Fong, T. G., Tulebaev, S. R., Inouye, S. K., (2011). Delirium in elderly adults: diagnosis, prevention and treatment.
Nature Review Neurology 5, 210-220. doi: [10.1038/nrneurol.2009.24]
 Francis, Joseph. “Prevention and Treatment of Delirium and Confusional States”. Up-to-date 2011.
 Grover S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine and risperidone in
delirium. J. Psychosom. Res. 2011; 71: 277–281.
 Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics
2004; 45: 297–301.
 Han J, Wilson A, & Ely E., (2013). Delirium in the Older Emergency Department Patient – A Quiet Epidemic. Emerg
Med Clin North Am. doi: [10.1016/j.emc.2010.03.005]
 Hshieh, T. T., et al. (2015). "Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-
analysis." JAMA Intern Med 175(4): 512-520
 Inouye SK, Rushing JT, Foreman MD, et al: Does delirium contribute to poor hospital outcome? J Gen Intern Med
13:234-242, 1998.

Academy of Consultation-Liaison Psychiatry 34


REFERENCES

 Inouye, S., van Dyck, C., Alessi, C., Balkin, S., Siegal, A., Horwitz, R., (1990). Clarifying confusion: The confusion
assessment method. Annuals of Internal Medicine, 113(12), 941-948.
 Kalish, V. B., et al. (2014). "Delirium in older persons: evaluation and management." Am Fam Physician 90(3): 150-
158.
 Khan, B. A., et al. (2015). "Update on Pharmacotherapy for Prevention and Treatment of Post-operative Delirium:
A Systematic Evidence Review." Curr Anesthesiol Rep 5(1): 57-64.
 Kim, S., et al. (2017). "Delirium characteristics and outcomes in medical and surgical lnpatients: A subgroup
analysis." J Crit Care 43: 156-162.
 Kooi, W. A., Zaal, I., Klijn, F., Koek, L. K., Meijer, C. R., Leijten, F., Slooter, A., (2015). Delirium Detection Using EEG.
Chest 1 (147) 94-101.
 Lewis LM, Miller DK, Morley JE, et al: Unrecognized delirium in ED geriatric patients. Am J Emerg Med. 13(2):142-
5, 1995.
 McCusker, J., Cole, M., Dendukuri, N., Han, Ling., Belzile., (2003). The Course of Delirium in Older Medical
Inpatients. A prospective study. Journal of General Internal Medicine 18(9) 696-704. doi: [
10.1046/j.1525-1497.2003.20602.x]

Academy of Consultation-Liaison Psychiatry 35


REFERENCES

 Morandi, A., Pandharipande, P., Trabucchi, M. et al. Intensive Care Med (2008) 34: 1907.
https://doi.org/10.1007/s00134-008-1177-6
 Oldham, M. A., et al. (2017). "Responding to Ten Common Delirium Misconceptions With Best Evidence: An
Educational Review for Clinicians." J Neuropsychiatry Clin Neurosci: appineuropsych17030065
 Miller, Marcia O. “Evaluation and Management of Delirium in Hospitalized Older Patients”. American Family
Physician, vol. 78, no. 11; pp. 1265-1270, December 1, 2008.
 Remington, Gary and Kapur, Shitij. “Antipsychotic Dosing: How Much but also How Often?”. Schizophrenia
Bulletin, vol. 36 no. 5 pp. 900-903, July 21, 2010.
 Rockwell K, Cosway S, Stolee P, et al: Increasing the recognition of delirium in elderly patients. J Am Geriatr Soc.
42(3):252-6, 1994.
 Tahir TA, Eeles E, Karapareddy V et al. A randomized controlled trial of quetiapine versus placebo in the treatment
of delirium. J. Psychosom. Res. 2010; 69: 485–490.
 Taylor, John B, et al: Delirium. In Massachusetts, General Hospital: Psychiatry Update and Board Preparation.
MGH Psychiatry Academy Publishing, 2012.

Academy of Consultation-Liaison Psychiatry 36


REFERENCES

 The Cochran Collaboration. “Antipsychotics for Delirium”. Published by John Wiley & Sons, Ltd. Issue 1, 2009.
 Sandeep, Grover et al. “Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium”.
Journal of Psychosomatic Research; vol. 71, issue 4, pp. 277-281, October 2011.
 Serafim, R. B., et al. (2015). "Pharmacologic prevention and treatment of delirium in intensive care patients: A
systematic review." J Crit Care 30(4): 799-807.
 Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: Treating delirium in a critical care
setting. Intensive Care Med. 2004; 30: 444–449.
 Soiza, R., Sharma, V., Ferguson, K., Shenkin S., Seymour, D., MacLullich, A., (2008). Neuroimaging studies of
delirium: A systemic review. Journal of Psychosomatic Research 65(3) 239-248.
 Stahl, S. M: Essential Psychopharmacology, 4th Ed. Cambridge University Press, 2016
 Virtual Mentor. 2008. Differentiating among Depression, Delirium, and Dementia in Elderly Patients. 10(6):383-
388. doi: 10.1001/virtualmentor.2008.10.6.cprl1-0806
 Wang, Phillip et al. “Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications”. New
England Journal of Medicine; 353; pp. 2335-2341; December 2005.
 Wong, Camilla, et al. “Does This Patient Have Delirium? Value of Bedside Instruments”. Journal of the American
Medical Association, vol. 304, no. &; pp 779-785; August 18, 2010.
Academy of Consultation-Liaison Psychiatry 37

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy